Skip to search formSkip to main contentSkip to account menu

Ergot Derivatives

Known as: ergot derivative 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson’s disease
PurposeSome studies have suggested a potential risk of heart failure in patients with Parkinson’s disease receiving dopamine (DA… 
2009
2009
B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist
Objective: To elucidate the usefulness of plasma B-type natriuretic peptide (BNP) values for evaluating adverse effects of… 
2003
2003
Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness.
2002
2002
Fibrosis due to ergot derivatives: exposure to risk should be weighed up.
  • Prescrire international
  • 2002
  • Corpus ID: 30037581
(1) Ergot derivatives are used for a variety of indications, including migraine, Parkinson's disease, endocrine disorders, and… 
2000
2000
Severe postpartum hypertension and reversible cerebral angiopathy associated with ergot derivative (methergoline) administration.
A 36-year-old woman (gravida 2, para 2) delivered a healthy child by cesarean section at the 37th week of an unremarkable… 
1991
1991
Hysteroscopic Laser Ablation of the Endometrium
Menorrhagia represents a widespread clinical problem, and is the leading cause of elective hysterectomy in women with a normal… 
1988
1988
Dihydroergocristine and memory alterations of aged male rats
1987
1987
Pharmacokinetics of bromerguride, antagonistic ergot derivative in rat a new dopamine ­ and dog
SUMMARY Bromerguride is a novel dopamine antagonistic ergot derivative in which a complete reversed pharmacodynamic profile has… 
1983
1983
Changes of pituitary secretion after long-term treatment with hydergine, in elderly patients.
The aim of this study was to evaluate the effects of long-term treatment with an ergot derivative, dihydroergotoxine mesylate… 
1975
1975
[Prevention of postpartum lactation using a new ergot derivative: 2-Br-alpha-ergocryptine or CB-154. Comparison with chlorotrianisene].
18 postpartum women took 2.5 mg bromocryptine (2-bromo-alpha-ergocryptine or CB-154 Sandoz) for 14 days and 20 took 24 mg… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)